Publications by authors named "Michael Baehr"

Claim this Profile
D
Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children.
Adrin Dadkhah, Tobias Gutowski, Eva-Maria Wansing, Alexander von Hugo, Wilhelm Woessmann, Michael Baehr

Int J Pharm X· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022.
Marlene Ettemeyer, Maria Florey, Konstantin Tanida, Johannes Jochum, Ulf Schulze-Sturm, Michael Baehr

Infection· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Unified Data Architecture for Assessing Motor Symptoms in Parkinson's Disease.
Christopher Gundler, Qi Rui Zhu, Leona Trübe, Adrin Dadkhah, Tobias Gutowski, Michael Baehr

Stud Health Technol Inform· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacy services in critical care: results of an observational study comparing ward-based with remote pharmacy services.
Heike Hilgarth, Dominic Wichmann, Michael Baehr, Stefan Kluge, Claudia Langebrake

Int J Clin Pharm· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an immediate release excipient composition for 3D printing via direct powder extrusion in a hospital.
Moritz Rosch, Tobias Gutowski, Michael Baehr, Jan Eggert, Karl Gottfried

Int J Pharm· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of pharmacists' interventions within the Closed Loop Medication Management process on medication safety: An analysis in a German university hospital.
Vivien Berger, Christian Sommer, Peggy Boje, Josef Hollmann, Julia Hummelt, Michael Baehr

Front Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.
Dzenefa Alihodzic, Sebastian G Wicha, Otto R Frey, Christina König, Michael Baehr

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare.
Caroline Krüger, Ingmar Schäfer, Hendrik van den Bussche, Michael Baehr, Horst Bickel

Eur J Gen Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients.
Christoph Schwering, Gertrud Kammler, Eva Wibbeler, Martin Christner, Johannes K-M Knobloch, Michael Baehr

J Child Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing.
Dzenefa Alihodzic, Astrid Broeker, Michael Baehr, Stefan Kluge, Claudia Langebrake

Front Pharmacol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study.
Stephan Braune, Christina König, Jason A Roberts, Axel Nierhaus, Oliver Steinmetz, Michael Baehr

Crit Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and dosing simulations of ceftazidime in critically ill patients receiving sustained low-efficiency dialysis.
Christina König, Stephan Braune, Jason A Roberts, Axel Nierhaus, Oliver M Steinmetz, Michael Baehr

J Antimicrob Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.
Juri Katchanov, Benno Kreuels, Florian P Maurer, Kai Wöstmann, Johannes Jochum, Michael Baehr

BMC Infect Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially Inappropriate Medication Use in Multimorbid Elderly Inpatients: Differences Between the FORTA, PRISCUS and STOPP Ratings.
Beate Wickop, Steffen Härterich, Christian Sommer, Anne Daubmann, Michael Baehr

Drugs Real World Outcomes· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Formal criteria for good prescribing in the hospital].
Claudia Langebrake, Simone Melzer, Michael Baehr

Ther Umsch· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence.
Dorit Stange, Levente Kriston, Alessa von-Wolff, Michael Baehr, Dorothee C Dartsch

J Manag Care Pharm· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete medication adherence of chronically ill patients in German primary care.
Jakob Hüther, Alessa von Wolff, Dorit Stange, Martin Härter, Michael Baehr

Patient Prefer Adherence· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care.
Dorit Stange, Levente Kriston, Alessa von Wolff, Michael Baehr, Dorothee C Dartsch

Eur J Clin Pharmacol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI-D).
Dorit Stange, Levente Kriston, Claudia Langebrake, Lynda K Cameron, John D Wollacott, Michael Baehr

J Eval Clin Pract· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
Claudia Langebrake, Friederike Bernhardt, Michael Baehr, Nicolaus Kröger, Axel R Zander

Int J Clin Pharm· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward?
Carola Dehmel, Stephan A Braune, Georg Kreymann, Michael Baehr, Claudia Langebrake

Intensive Care Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.
Falk Kiefer, Holger Jahn, Timo Tarnaske, Hauke Helwig, Peer Briken, Michael Baehr

Arch Gen Psychiatry· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis